Effects of moxonidine on corticocerebral blood flow under normal and ischemic conditions in conscious rabbits

Journal of Cardiovascular Pharmacology

Volumn 35, Issue 3, 2000, Pages 417-421

  Csete, Klára ^a   Papp, Julius Gy ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Conscious rabbits; Corticocerebral blood flow; Hydrogen polarography; I1; Imidazoline receptors; Moxonidine

Indexed keywords

CATECHOLAMINE; IMIDAZOLINE I1 RECEPTOR; MOXONIDINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD BRAIN BARRIER; BRAIN BLOOD FLOW; BRAIN ISCHEMIA; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR RISK; CATECHOLAMINE RELEASE; CONTROLLED STUDY; DRUG EFFECT; DRUG PENETRATION; DRUG RECEPTOR BINDING; FEMALE; HEART RATE; HYPERTENSION; LIPOPHILICITY; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; POLAROGRAPHY; PRIORITY JOURNAL; RABBIT;

ANALYSIS OF VARIANCE; ANIMALS; BLOOD PRESSURE; CEREBRAL CORTEX; CEREBROVASCULAR CIRCULATION; FEMALE; HEART RATE; IMIDAZOLES; INJECTIONS, INTRAVENOUS; ISCHEMIA; MALE; PLATELET AGGREGATION INHIBITORS; POLAROGRAPHY; RABBITS;

EID: 0034004289     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200003000-00011     Document Type: Article

References (2)

1. Stokes J, Kaunel WB, Wolf PA, D'Agostino RB, Cupples LA. Blood pressure as a risk factor for cardiovascular disease: the Framingham Study: 30 years of follow up. Hypertension 1989;13 (suppl 1):13-8.
2. 1-imidazoline sites. J Pharmacol Exp Ther 1993; 264:172-82.